Skip to main content
Top
Published in: Rheumatology International 9/2012

01-09-2012 | Original Article

Prevalence and clinical presentations of hepatitis C virus among patients admitted to the rheumatology ward

Authors: Ayman El Garf, Bassel El Zorkany, Rasha Gheith, Hala Sheba, Geilan Abdel Moneim, Kamal El Garf

Published in: Rheumatology International | Issue 9/2012

Login to get access

Abstract

To study the prevalence of anti-HCV antibodies among patients admitted to the rheumatology department, Cairo University hospitals, in 6-month period as well as to determine whether chronic HCV infection was the primary cause of their admission or just a concomitant association with the rheumatic disease. One hundred and fifty-seven patients were included in this study. They represent all patients admitted to the rheumatology inpatient department of Cairo University hospitals during the study period. Preset questionnaire including detailed demographic data, cause of admission and clinical manifestations of their disease was obtained for every patient. All patients were screened for HCV antibodies using ELISA technique. Other laboratory and imaging investigations were done according to the patient’s diagnosis. Twenty-nine patients (18.5%) were positive for HCV antibody. Eleven patients of them (38%) were admitted due to rheumatic manifestations directly related to chronic HCV infection, which represent 7% of all admitted patients (11/157). HCV antibodies were found in 17.6 and 6.7% among patients with rheumatoid and systemic lupus erythematosus. Arthritis, palpaple purpura, digital gangrene and mononeuritis multiplex were the most common causes of admission related to chronic HCV infection. HCV antibodies were found in 18.5% among admitted patients to the rheumatology ward. The rheumatic manifestations of chronic HCV represent the primary cause of admission in 7% of all admitted patients. HCV screening should be included in the routine investigations for patients presenting to rheumatology departments in countries with high prevalence of chronic HCV infection.
Literature
1.
go back to reference Rustgi VD (2007) The epidemiology of hepatitis C infection in the United States. J Gastroenterol 42:513–521PubMedCrossRef Rustgi VD (2007) The epidemiology of hepatitis C infection in the United States. J Gastroenterol 42:513–521PubMedCrossRef
2.
go back to reference Strickland GT, Elhefni H, Salman T, Waked I, Abdel-Hamid M, Mikhail NN et al (2002) Role of hepatitis C infection in chronic liver disease in Egypt. Am J Trop Med Hyg 67(4):436–442PubMed Strickland GT, Elhefni H, Salman T, Waked I, Abdel-Hamid M, Mikhail NN et al (2002) Role of hepatitis C infection in chronic liver disease in Egypt. Am J Trop Med Hyg 67(4):436–442PubMed
3.
go back to reference Strickland GT (2006) Liver disease in Egypt: hepatitis C superseded schistosomiasis as a result of iatrogenic and biological factors. Hepatology 43(5):915–922PubMedCrossRef Strickland GT (2006) Liver disease in Egypt: hepatitis C superseded schistosomiasis as a result of iatrogenic and biological factors. Hepatology 43(5):915–922PubMedCrossRef
4.
go back to reference Armstrong GL, Walsley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ (2006) The prevalence of hepatitis C virus infection in the United States, 199 through 2002. Ann Intern Med 144(10):705–714PubMed Armstrong GL, Walsley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ (2006) The prevalence of hepatitis C virus infection in the United States, 199 through 2002. Ann Intern Med 144(10):705–714PubMed
5.
go back to reference Shalaby S, Kabbash IA, El Saleet G, Mansour N, Omar A, El Nawawy A (2010) Hepatitis B and C viral infection: prevalence, knowledge, attitude and practice among barbers and clients in Gharbia governerate, Egypt. East Mediterr Health J 16(1):10–17PubMed Shalaby S, Kabbash IA, El Saleet G, Mansour N, Omar A, El Nawawy A (2010) Hepatitis B and C viral infection: prevalence, knowledge, attitude and practice among barbers and clients in Gharbia governerate, Egypt. East Mediterr Health J 16(1):10–17PubMed
6.
go back to reference El-Zayadi A, Simmonds P, Dabbous H, Prescott L, Selim O, Ahdy A (1996) Response to interferon-a of Egyptian patients infected with hepatitis C virus genotype 4. J Viral Hepat 3:261–264PubMedCrossRef El-Zayadi A, Simmonds P, Dabbous H, Prescott L, Selim O, Ahdy A (1996) Response to interferon-a of Egyptian patients infected with hepatitis C virus genotype 4. J Viral Hepat 3:261–264PubMedCrossRef
7.
go back to reference Angelico M, Renganathan E, Gandin C, Fathy M, Profili MC, Refai W et al (1997) Chronic liver disease in the Alexandria governorate, Egypt: contribution of schistosomiasis and hepatitis virus infections. J Hepatol 26(2):236–243PubMedCrossRef Angelico M, Renganathan E, Gandin C, Fathy M, Profili MC, Refai W et al (1997) Chronic liver disease in the Alexandria governorate, Egypt: contribution of schistosomiasis and hepatitis virus infections. J Hepatol 26(2):236–243PubMedCrossRef
8.
go back to reference Ray SC, Arthur RR, Carella A, Bukh J, Thomas DL (2000) Genetic epidemiology of hepatitis C virus throughout Egypt. J Infect Dis 182:698–707PubMedCrossRef Ray SC, Arthur RR, Carella A, Bukh J, Thomas DL (2000) Genetic epidemiology of hepatitis C virus throughout Egypt. J Infect Dis 182:698–707PubMedCrossRef
9.
go back to reference Kamal SM, Madwar MA, Peters T, Fawzy R, Rasenack J (2000) Interferon therapy in patients with chronic hepatitis C and schistosomiasis. J Hepatol 32:172–174PubMedCrossRef Kamal SM, Madwar MA, Peters T, Fawzy R, Rasenack J (2000) Interferon therapy in patients with chronic hepatitis C and schistosomiasis. J Hepatol 32:172–174PubMedCrossRef
10.
go back to reference McCarthy MC, El Tigani A, Khalid IO, Hyams KC (1994) Hepatitis B and C in Juba, southern Sudan: results of a serosurvey. Trans Roy Soc Top Med Hyg 88:534–536CrossRef McCarthy MC, El Tigani A, Khalid IO, Hyams KC (1994) Hepatitis B and C in Juba, southern Sudan: results of a serosurvey. Trans Roy Soc Top Med Hyg 88:534–536CrossRef
11.
go back to reference World Health Organization (WHO) (1997) Hepatis C global prevalence. Wkly Epidemiological Rec 72:341–344 World Health Organization (WHO) (1997) Hepatis C global prevalence. Wkly Epidemiological Rec 72:341–344
12.
go back to reference Shobokshi O, Serebour E, Shakni L, Al Saffy Y, Ahdai M (1999) Hepatitis C genotypes and subtypes in Saudi Arabia. J Med Virol 58(1):44–48PubMedCrossRef Shobokshi O, Serebour E, Shakni L, Al Saffy Y, Ahdai M (1999) Hepatitis C genotypes and subtypes in Saudi Arabia. J Med Virol 58(1):44–48PubMedCrossRef
13.
go back to reference Quinti I, Renganathan E, El Ghazzawi E, Divizia M, Sawaf G, Awad S et al (1995) Seroprevalence of HIV and HCV infections in Alexandria, Egypt. Zentralbl Bakteriol 283(2):239–244PubMedCrossRef Quinti I, Renganathan E, El Ghazzawi E, Divizia M, Sawaf G, Awad S et al (1995) Seroprevalence of HIV and HCV infections in Alexandria, Egypt. Zentralbl Bakteriol 283(2):239–244PubMedCrossRef
14.
go back to reference Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur R, Magder L et al (2000) The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 355(9207):887–891PubMedCrossRef Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur R, Magder L et al (2000) The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 355(9207):887–891PubMedCrossRef
15.
go back to reference Nafeh MA, Medhat A, Shehata M, Mikhail NN, Swifee Y, Abdel-Hamid M et al (2000) Hepatitis C in a community in upper Egypt: I. cross-sectional survey. Am J Trop Med Hyg 63(5–6):236–241PubMed Nafeh MA, Medhat A, Shehata M, Mikhail NN, Swifee Y, Abdel-Hamid M et al (2000) Hepatitis C in a community in upper Egypt: I. cross-sectional survey. Am J Trop Med Hyg 63(5–6):236–241PubMed
16.
go back to reference Habib M, Mohamed MK, Abdel-Aziz F, Magder LS, Abdel-Hamid M, Madkour S et al (2001) Hepatitis C virus infection in a community in the Nile Delta: risk factors for seropositivity. Hepatology 33:248–253PubMedCrossRef Habib M, Mohamed MK, Abdel-Aziz F, Magder LS, Abdel-Hamid M, Madkour S et al (2001) Hepatitis C virus infection in a community in the Nile Delta: risk factors for seropositivity. Hepatology 33:248–253PubMedCrossRef
17.
go back to reference Cacoub P, Renou C, Rosenthal E, Cohen P, Loury I, Loustaud-Ratti V et al (2000) Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Medicine (Baltimore) 79(1):47–56CrossRef Cacoub P, Renou C, Rosenthal E, Cohen P, Loury I, Loustaud-Ratti V et al (2000) Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Medicine (Baltimore) 79(1):47–56CrossRef
18.
go back to reference Ramos-Casals M, Font J (2005) Extra-hepatic manifestations in patients with chronic hepatitis C virus infection. Curr Opin Rheumatol 17(4):447–455PubMed Ramos-Casals M, Font J (2005) Extra-hepatic manifestations in patients with chronic hepatitis C virus infection. Curr Opin Rheumatol 17(4):447–455PubMed
19.
go back to reference Sterling RK, Bralow S (2006) Extrahepatic manifestations of hepatitis C virus. Curr Gastroenterol Rep 8(1):53–59PubMedCrossRef Sterling RK, Bralow S (2006) Extrahepatic manifestations of hepatitis C virus. Curr Gastroenterol Rep 8(1):53–59PubMedCrossRef
20.
go back to reference Buskila D, Shnaider A, Neumann L, Lorber M, Zilberman D, Hilzenrat N et al (1998) Musculoskeletal manifestations and autoantibody profile in 90 hepatitis C virus-infected Israeli patients. Semin Arthritis Rheum 28(2):107–113PubMedCrossRef Buskila D, Shnaider A, Neumann L, Lorber M, Zilberman D, Hilzenrat N et al (1998) Musculoskeletal manifestations and autoantibody profile in 90 hepatitis C virus-infected Israeli patients. Semin Arthritis Rheum 28(2):107–113PubMedCrossRef
22.
go back to reference Lormeau C, Falgarone G, Roulot D, Boissier MC (2006) Rheumatologic manifestations of chronic hepatitis C infection. Joint Bone Spine 73(6):633–638PubMedCrossRef Lormeau C, Falgarone G, Roulot D, Boissier MC (2006) Rheumatologic manifestations of chronic hepatitis C infection. Joint Bone Spine 73(6):633–638PubMedCrossRef
23.
go back to reference Buskila D (2009) Hepatitis C-associated rheumatic disorders. Rheum Dis Clin North Am 35(1):111–123PubMedCrossRef Buskila D (2009) Hepatitis C-associated rheumatic disorders. Rheum Dis Clin North Am 35(1):111–123PubMedCrossRef
24.
go back to reference Ramos-Casals M, Jara LJ, Medina F, Rosas J, Calvo-Alen J, Mana J et al (2005) Systemic autoimmune diseases coexisting with chronic hepatitis C virus infection (the HISPAMIC Registry): patterns of clinical and immunological expression in 180 cases. J Intern Med 257(6):549–557PubMedCrossRef Ramos-Casals M, Jara LJ, Medina F, Rosas J, Calvo-Alen J, Mana J et al (2005) Systemic autoimmune diseases coexisting with chronic hepatitis C virus infection (the HISPAMIC Registry): patterns of clinical and immunological expression in 180 cases. J Intern Med 257(6):549–557PubMedCrossRef
25.
go back to reference Barbosa VS, da Silva NA, Martins RMB (2005) Hepatitis C virus seroprevelance and genotypes in patients with diffuse connective tissue diseases and spondyloarthopathies. Braz J Med Biol Res 38(5):801–805PubMedCrossRef Barbosa VS, da Silva NA, Martins RMB (2005) Hepatitis C virus seroprevelance and genotypes in patients with diffuse connective tissue diseases and spondyloarthopathies. Braz J Med Biol Res 38(5):801–805PubMedCrossRef
26.
go back to reference Pryor B, Bologna AG, Kahl LE (1996) Risk factors for serious infection during treatment with cyclophosphamide and high-dose corticosteroids for systemic lupus erythematosus. Arthritis Rheum 39:1475–1482PubMedCrossRef Pryor B, Bologna AG, Kahl LE (1996) Risk factors for serious infection during treatment with cyclophosphamide and high-dose corticosteroids for systemic lupus erythematosus. Arthritis Rheum 39:1475–1482PubMedCrossRef
27.
go back to reference Cansu DU, Kalifoglu T, Korkmaz C (2008) Short-term course of chronic hepatitis B and C under treatment with etanercept associated with different disease modifying antirheumatic drugs without antiviral prophylaxis. J Rheumatol 35(3):421–424PubMed Cansu DU, Kalifoglu T, Korkmaz C (2008) Short-term course of chronic hepatitis B and C under treatment with etanercept associated with different disease modifying antirheumatic drugs without antiviral prophylaxis. J Rheumatol 35(3):421–424PubMed
28.
29.
go back to reference Silini E, Locasciulli A, Santoleri L, Gargantini L, Pinzello G, Montillo M et al (2002) Hepatitis C virus infection in a hematology ward: evidence for nosocomial transmission and impact on hematologic disease outcome. Haematologica 87(11):1200–1208PubMed Silini E, Locasciulli A, Santoleri L, Gargantini L, Pinzello G, Montillo M et al (2002) Hepatitis C virus infection in a hematology ward: evidence for nosocomial transmission and impact on hematologic disease outcome. Haematologica 87(11):1200–1208PubMed
30.
go back to reference Allander T, Gruber A, Naghavi M, Beyene A, Soderstrom T, Bjorkholm M et al (1995) Frequent patient-to-patient transmission of hepatitis C virus in a haematology ward. Lancet 345(8950):603–607PubMedCrossRef Allander T, Gruber A, Naghavi M, Beyene A, Soderstrom T, Bjorkholm M et al (1995) Frequent patient-to-patient transmission of hepatitis C virus in a haematology ward. Lancet 345(8950):603–607PubMedCrossRef
31.
go back to reference Knoll A, Helmig M, Peters O, Jilg W (2001) Hepatitis C virus transmission in a pediatric oncology ward: analysis of an outbreak and review of the literature. Lab Invest 81(3):251–262PubMedCrossRef Knoll A, Helmig M, Peters O, Jilg W (2001) Hepatitis C virus transmission in a pediatric oncology ward: analysis of an outbreak and review of the literature. Lab Invest 81(3):251–262PubMedCrossRef
32.
go back to reference Girou E, Chevaliez S, Challine D, Thiessart M, Morice Y, Lesprit P et al (2008) Determinant roles of environmental contamination and noncompliance with standard precautions in the risk of hepatitis C virus transmission in a hemodialysis unit. Clin Infect Dis 47(5):627–633PubMedCrossRef Girou E, Chevaliez S, Challine D, Thiessart M, Morice Y, Lesprit P et al (2008) Determinant roles of environmental contamination and noncompliance with standard precautions in the risk of hepatitis C virus transmission in a hemodialysis unit. Clin Infect Dis 47(5):627–633PubMedCrossRef
33.
go back to reference Ross RS, Viazov S, Khudyakov YE, Xia GL, Lin Y, Holzmann H et al (2009) Transmission of hepatitis C virus in an orthopedic hospital ward. J Med Virol 81(2):249–257PubMedCrossRef Ross RS, Viazov S, Khudyakov YE, Xia GL, Lin Y, Holzmann H et al (2009) Transmission of hepatitis C virus in an orthopedic hospital ward. J Med Virol 81(2):249–257PubMedCrossRef
34.
go back to reference Steeff LB (2002) Natural history of chronic hepatitis C. Hepatology 36(5 Suppl 1):S35–S46 Steeff LB (2002) Natural history of chronic hepatitis C. Hepatology 36(5 Suppl 1):S35–S46
35.
go back to reference Lewis-Ximenez LL, Lauer GM, Schulze Zur Wiessch J, de Sousa PS, Ginuino CF, Paranhos-Baccala G et al (2010) Prospective follow-up of patients with acute hepatitis C virus infection in Brazil. Clin Infect Dis 50(9):1222–1230PubMedCrossRef Lewis-Ximenez LL, Lauer GM, Schulze Zur Wiessch J, de Sousa PS, Ginuino CF, Paranhos-Baccala G et al (2010) Prospective follow-up of patients with acute hepatitis C virus infection in Brazil. Clin Infect Dis 50(9):1222–1230PubMedCrossRef
36.
go back to reference Maillefert JF, Muller G, Falgarone G, Bour JB, Ratovohery D, Dougados M et al (2002) Prevalence of hepatitis C virus infection in patients with rheumatoid arthritis. Ann Rheum Dis 61(7):635–637PubMedCrossRef Maillefert JF, Muller G, Falgarone G, Bour JB, Ratovohery D, Dougados M et al (2002) Prevalence of hepatitis C virus infection in patients with rheumatoid arthritis. Ann Rheum Dis 61(7):635–637PubMedCrossRef
37.
go back to reference Palazzi C, D’Amico E, D’Angelo S, Nucera A, Petricca A, Olivieri I (2008) Hepatitis C virus infection in Italian patients with fibromyalgia. Clin Rheumatol 27(1):101–103PubMedCrossRef Palazzi C, D’Amico E, D’Angelo S, Nucera A, Petricca A, Olivieri I (2008) Hepatitis C virus infection in Italian patients with fibromyalgia. Clin Rheumatol 27(1):101–103PubMedCrossRef
38.
go back to reference Abu shakra M, El-Sana S, Margalith M, Silkuler E, Neumann L, Buskila D (1997) Hepatitis B and C viruses serology in patients with SLE. Lupus 6(6):543–544PubMedCrossRef Abu shakra M, El-Sana S, Margalith M, Silkuler E, Neumann L, Buskila D (1997) Hepatitis B and C viruses serology in patients with SLE. Lupus 6(6):543–544PubMedCrossRef
Metadata
Title
Prevalence and clinical presentations of hepatitis C virus among patients admitted to the rheumatology ward
Authors
Ayman El Garf
Bassel El Zorkany
Rasha Gheith
Hala Sheba
Geilan Abdel Moneim
Kamal El Garf
Publication date
01-09-2012
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 9/2012
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-011-2014-8

Other articles of this Issue 9/2012

Rheumatology International 9/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.